JP2003201211A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JP2003201211A JP2003201211A JP2001400323A JP2001400323A JP2003201211A JP 2003201211 A JP2003201211 A JP 2003201211A JP 2001400323 A JP2001400323 A JP 2001400323A JP 2001400323 A JP2001400323 A JP 2001400323A JP 2003201211 A JP2003201211 A JP 2003201211A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- cream
- fish
- cosmetic
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 22
- 108010035532 Collagen Proteins 0.000 claims abstract description 36
- 102000008186 Collagen Human genes 0.000 claims abstract description 36
- 229920001436 collagen Polymers 0.000 claims abstract description 36
- 241000251468 Actinopterygii Species 0.000 claims abstract description 16
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 15
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 12
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960001484 edetic acid Drugs 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 8
- 229960001295 tocopherol Drugs 0.000 claims abstract description 8
- 229930003799 tocopherol Natural products 0.000 claims abstract description 8
- 239000011732 tocopherol Substances 0.000 claims abstract description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 8
- 108010045569 atelocollagen Proteins 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 abstract description 13
- 230000003405 preventing effect Effects 0.000 abstract description 9
- 238000009472 formulation Methods 0.000 abstract description 7
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 239000006071 cream Substances 0.000 description 27
- 230000000694 effects Effects 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 19
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 235000019645 odor Nutrition 0.000 description 14
- 235000019688 fish Nutrition 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 229940042585 tocopherol acetate Drugs 0.000 description 8
- 239000012071 phase Substances 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- -1 tetrasodium edetate tetrahydrate Chemical class 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 2
- 241000252229 Carassius auratus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 239000013040 bath agent Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019515 salmon Nutrition 0.000 description 2
- 238000005185 salting out Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000923 atherogenic effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930000755 gossypol Natural products 0.000 description 1
- 229950005277 gossypol Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- KSYNLCYTMRMCGG-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;dihydrate Chemical compound O.O.[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O KSYNLCYTMRMCGG-UHFFFAOYSA-J 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、魚由来コラーゲン
配合化粧料の安定化に関し、さらに詳しくは製剤中の異
臭防止効果に関する。TECHNICAL FIELD The present invention relates to the stabilization of cosmetics containing fish-derived collagen, and more particularly to the effect of preventing off-flavors in preparations.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】一般に
コラーゲンは、化粧料中にシワなどの老化予防や改善目
的に配合されたり、皮膚の潤いを保つために保湿剤とし
て汎用される原料である。中でも魚由来コラーゲンは魚
より抽出精製されるコラーゲンで、タンパク質としての
変性温度が低いことより哺乳動物のコラーゲンよりシワ
改善や皮膚の潤いを保つ効果に優れているとされる。BACKGROUND OF THE INVENTION Collagen is generally a raw material commonly used as a moisturizing agent in cosmetics for the purpose of preventing and improving aging such as wrinkles and for keeping skin moisturized. . Among them, fish-derived collagen is collagen extracted and purified from fish, and it is said that collagen having a lower denaturation temperature as a protein is more effective in improving wrinkles and maintaining skin moisture than collagen of mammals.
【0003】しかし、この魚由来コラーゲンは抽出精製
段階で除去不可能な魚油がごく微量混入するため、化粧
料に配合した場合、温度の影響で異臭が発生する欠点が
あった。However, this fish-derived collagen contains a very small amount of fish oil that cannot be removed in the extraction and purification step, and thus has a drawback that when it is incorporated into a cosmetic composition, an offensive odor is generated under the influence of temperature.
【0004】そこで、異臭を伴わずに魚由来コラーゲン
を配合する技術の開発が望まれていた。Therefore, it has been desired to develop a technique for blending fish-derived collagen with no offensive odor.
【0005】[0005]
【課題を解決するための手段】本発明者らは、かかる事
情に鑑み鋭意努力した結果、後述する特定の成分を含有
する化粧料が、魚由来コラーゲンの異臭を防止する作用
を示すことを見出し、本発明を完成するに至った。Means for Solving the Problems As a result of diligent efforts in view of such circumstances, the present inventors have found that a cosmetic containing a specific component described below has an action of preventing the offensive odor of fish-derived collagen. The present invention has been completed.
【0006】すなわち、本発明は魚由来コラーゲンと酸
化防止剤を含有することを特徴とした化粧料で、酸化防
止剤の中でも特にエデト酸又はその塩、及び/又はトコ
フェロール又はその誘導体を含有することを特徴とした
化粧料を提供するものである。That is, the present invention is a cosmetic characterized in that it contains fish-derived collagen and an antioxidant, and in particular, it contains edetic acid or a salt thereof and / or tocopherol or a derivative thereof among antioxidants. The cosmetics are characterized by
【0007】本発明に使用される酸化防止剤としては、
例えばトコフェロール又はその誘導体、エデト酸又はそ
の塩、セサモール、セサモリン、ゴシポール、リン脂質
等の天然品や、その他例えばブチルヒドロキシアニソー
ル、ジブチルヒドロキシトルエン等の合成品が好ましい
ものとして挙げられる。As the antioxidant used in the present invention,
Preferred examples include natural products such as tocopherol or a derivative thereof, edetic acid or a salt thereof, sesamol, sesamolin, gossypol and phospholipid, and other synthetic products such as butylhydroxyanisole and dibutylhydroxytoluene.
【0008】中でもエデト酸又はその塩、及び/又はト
コフェロール又はその誘導体は、本発明者の探求によ
り、上記の酸化防止剤の中で効果が最も高いことを見出
した。Among them, edetic acid or a salt thereof and / or tocopherol or a derivative thereof have been found to have the highest effect among the above-mentioned antioxidants by the search of the present inventor.
【0009】エデト酸又はその塩としては、エデト酸2
ナトリウム、エデト酸3ナトリウム、エデト酸4ナトリ
ウム2水塩、エデト酸4ナトリウム4水塩等が挙げられ
る。As edetic acid or its salt, edetic acid 2
Examples thereof include sodium, trisodium edetate, tetrasodium edetate dihydrate, and tetrasodium edetate tetrahydrate.
【0010】トコフェロール又はその誘導体としては、
酢酸トコフェロール、ニコチン酸トコフェロール等が挙
げられる。As tocopherol or its derivative,
Examples thereof include tocopherol acetate and tocopherol nicotinate.
【0011】本発明で使用する酸化防止剤は、天然品あ
るいは化学合成されたものを用いることができるが、製
法については特に限定されない。また、上記酸化防止剤
は、市販品を用いることができる。The antioxidant used in the present invention may be a natural product or a chemically synthesized product, but the manufacturing method is not particularly limited. A commercially available product can be used as the antioxidant.
【0012】酸化防止剤の本発明の化粧料への配合量
は、特に限定されないが、0.005〜5重量%(以
下、単に「%」で示す)、好ましくは0.05〜3%で
充分な異臭防止効果が得られ、保存安定性や使用感に優
れているので望ましい。The amount of the antioxidant added to the cosmetic of the present invention is not particularly limited, but is 0.005 to 5% by weight (hereinafter simply referred to as "%"), preferably 0.05 to 3%. It is desirable because it has a sufficient effect of preventing offensive odors and has excellent storage stability and usability.
【0013】上記酸化防止剤のうち、一種又は二種以上
が本発明の化粧料に配合される。[0013] Of the above antioxidants, one or two or more kinds are blended in the cosmetic of the present invention.
【0014】本発明に用いる魚由来のコラーゲンは、例
えば以下に示すものが挙げられる。魚としては、例え
ば、鮭、金目鯛、たら、ひらめ等の皮又は浮袋等を洗
浄、脱脂、酸濾過、酵素処理、塩析、透析、熱処理等の
手段を経て、可溶化コラーゲン成分を抽出した後、得ら
れるものが挙げられる。これらは、魚由来コラーゲン水
溶液として一般に市販されている。アテロ化処理して
も、加水分解処理しないでも良い。Examples of fish-derived collagen used in the present invention include those shown below. As the fish, for example, the solubilized collagen component was extracted through washing, degreasing, acid filtration, enzyme treatment, salting-out, dialysis, heat treatment, etc. of skins such as salmon, goldfish, codfish, flounder and the like. After that, what can be obtained is mentioned. These are generally commercially available as a fish-derived collagen aqueous solution. It does not need to be an atherogenic treatment or a hydrolysis treatment.
【0015】溶液のまま用いても良く、必要に応じて、
濃縮、希釈、濾過等の処理及び活性炭等による脱色、脱
臭処理をして用いても良い。さらには、抽出した溶液を
濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物
として用いても良い。The solution may be used as it is, and if necessary,
It may be used after being subjected to treatments such as concentration, dilution and filtration, and decolorization and deodorization with activated carbon or the like. Furthermore, the extracted solution may be concentrated to dryness, spray-dried, freeze-dried and the like and used as a dried product.
【0016】本発明に用いる魚由来のコラーゲンの配合
量は、特に限定されないが、好ましくは本発明における
化粧料の全量に対し、固形分に換算して0.0001%
以上が良く、さらに好ましくは0.0005〜50%が
良い。0.0001%未満では十分な効果は発揮され難
い。50%を越えて配合した場合、効果の増強は少なく
不経済である。また、添加の方法については、予め加え
ておいても、製造途中で添加しても良く、作業性を考え
て適宜選択すれば良い。The amount of fish-derived collagen used in the present invention is not particularly limited, but is preferably 0.0001% in terms of solid content based on the total amount of the cosmetic of the present invention.
The above is preferable, and 0.0005 to 50% is more preferable. If it is less than 0.0001%, it is difficult to exert a sufficient effect. When it is blended over 50%, the enhancement of the effect is small and it is uneconomical. Regarding the method of addition, it may be added in advance or may be added during the production, and may be appropriately selected in consideration of workability.
【0017】本発明の化粧料においては、必要に応じ、
本発明の効果を損なわない範囲において、上記成分の他
に通常化粧品、医薬部外品、医薬品等に用いられる各種
成分を必要に応じて適宜配合することができる。このよ
うな成分としては、例えば、精製水、エタノール、油性
物質、保湿剤、増粘剤、防腐剤、乳化剤、薬効成分、粉
体、色素、香料、乳化安定剤、pH調節剤等が挙げられ
る。In the cosmetic of the present invention, if necessary,
In addition to the above components, various components usually used in cosmetics, quasi drugs, pharmaceuticals and the like can be appropriately blended as needed, as long as the effects of the present invention are not impaired. Examples of such components include purified water, ethanol, oily substances, moisturizers, thickeners, preservatives, emulsifiers, medicinal components, powders, dyes, fragrances, emulsion stabilizers, pH adjusters and the like. .
【0018】本発明の化粧料は、化粧品及び医薬部外品
のいずれにも用いることができ、その剤型としては、例
えば、化粧水、クリーム、乳液、ゲル剤、エアゾール
剤、エッセンス、パック、洗浄剤、浴用剤、ファンデー
ション、打粉、口紅等が挙げられる。The cosmetics of the present invention can be used in both cosmetics and quasi-drugs, and examples of their dosage forms include lotion, cream, emulsion, gel, aerosol, essence, pack, Examples include cleaning agents, bath agents, foundations, dusting powders, lipsticks and the like.
【0019】[0019]
【実施例】次に本発明を詳細に説明するため、実施例と
して本発明に用いる抽出物の製造例、本発明の処方例及
び実験例を挙げるが、本発明はこれに限定されるもので
はない。EXAMPLES In order to explain the present invention in detail, production examples of the extract used in the present invention, prescription examples of the present invention and experimental examples will be given below, but the present invention is not limited thereto. Absent.
【0020】製造例1 酸可溶性アテロ化魚由来コラー
ゲン溶液
鮭の皮を洗浄処理、脱脂、酸処理、濾過、酵素処理、塩
析、等電点沈殿、透析を経て酸可溶性コラーゲン溶液を
得る。例えば、「酸可溶性アテロ化マリンコラーゲン溶
液」(井原水産製、乾燥残分1%)が挙げられる。Production Example 1 Acid-Soluble Atherosclerotic Fish-Derived Collagen Solution Salmon skin is washed, defatted, acid-treated, filtered, enzyme-treated, salted out, isoelectrically precipitated, and dialyzed to obtain an acid-soluble collagen solution. For example, an “acid-soluble atelo-ized marine collagen solution” (Ibara Suisan Co., Ltd., dry residue 1%) can be mentioned.
【0021】製造例2 水溶性魚由来コラーゲン溶液
金目鯛の皮を洗浄処理、脱脂、酸処理、濾過、塩析、透
析を経て酸可溶性コラーゲン溶液を得る。例えば、「水
溶性マリンコラーゲン溶液」(テクノーブル製、乾燥残
分0.3%)が挙げられる。Production Example 2 Water-Soluble Fish-Derived Collagen Solution An acid-soluble collagen solution is obtained by washing, degreasing, acid-treating, filtering, salting-out and dialysis the goldfish snapper skin. For example, "water-soluble marine collagen solution" (Technoble, dry residue 0.3%) can be mentioned.
【0022】
実施例1 クリーム
処方 配合量
1.エデト酸2ナトリウム 0.05部
2.酸可溶性アテロ化マリンコラーゲン溶液(井原水産製) 30.0
3.スクワラン 5.5
4.オリーブ油 3.0
5.ステアリン酸 2.0
6.ミツロウ 2.0
7.ミリスチン酸オクチルドデシル 3.5
8.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
9.ベヘニルアルコール 1.5
10.モノステアリン酸グリセリン 2.5
11.香料 0.1
12.1,3−ブチレングリコール 8.5
13.パラオキシ安息香酸エチル 0.05
14.パラオキシ安息香酸メチル 0.2
15.精製水にて全量を100とする
[製造方法]成分3〜10を加熱溶解して混合し、70
℃に保ち油相とする。成分1,2及び12〜15を加熱
溶解して混合し、75℃に保ち水相とする。油相に水相
を加えて乳化して、かき混ぜながら冷却し、45℃にて
成分11を加え、更に30℃まで冷却して製品とする。Example 1 Cream Formulation Amount 1. Disodium edetate 0.05 part 2. Acid-soluble atherinated marine collagen solution (Ihara Suisan) 30.0 3. Squalane 5.5 4. Olive oil 3.0 5. Stearic acid 2.0 6. Beeswax 2.0 7. Octyldodecyl myristate 3.5 8. Polyoxyethylene cetyl ether (20 EO) 3.0 9. Behenyl alcohol 1.5 10. Glycerin monostearate 2.5 11. Fragrance 0.1 12.1, 3-butylene glycol 8.5 13. Ethyl paraoxybenzoate 0.05 14. Methyl paraoxybenzoate 0.2 15. [Manufacturing method] The total amount is 100 with purified water. Components 3 to 10 are dissolved by heating and mixed, and 70
Keep at ℃ and use as oil phase. Components 1, 2 and 12 to 15 are melted by heating and mixed, and the mixture is kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, the mixture is cooled with stirring, component 11 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
【0023】
実施例2 化粧水
処方 配合量
1.エデト酸2ナトリウム 0.1部
2.酸可溶性アテロ化マリンコラーゲン溶液(井原水産製) 0.05
3.1,3−ブチレングリコール 8.0
4.グリセリン 2.0
5.キサンタンガム 0.02
6.クエン酸 0.01
7.クエン酸ナトリウム 0.1
8.エタノール 5.0
9.パラオキシ安息香酸メチル 0.1
10.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
11.香料 適量
12.精製水にて全量を100とする
[製造方法]成分1〜7及び12と、成分8〜11をそ
れぞれ均一に溶解し、両者を混合し濾過して製品とす
る。Example 2 Lotion Formulation Amount 1. Disodium edetate 0.1 part 2. Acid-soluble atherosclerosis marine collagen solution (made by Ihara Suisan) 0.05 3.1, 3-butylene glycol 8.0 4. Glycerin 2.0 5. Xanthan gum 0.02 6. Citric acid 0.01 7. Sodium citrate 0.1 8. Ethanol 5.0 9. Methyl paraoxybenzoate 0.1 10. Polyoxyethylene hydrogenated castor oil (40 EO) 0.1 11. Perfume proper amount 12. [Production method] The total amount is 100 with purified water Components 1 to 7 and 12 and components 8 to 11 are uniformly dissolved, and both are mixed and filtered to obtain a product.
【0024】
実施例3 乳液
処方 配合量
1.エデト酸2ナトリウム 0.5部
2.酢酸トコフェロール 1.0
3.酸可溶性アテロ化マリンコラーゲン溶液(井原水産製) 1.0
4.スクワラン 5.0
5.オリーブ油 5.0
6.ホホバ油 5.0
7.セタノール 1.5
8.モノステアリン酸グリセリン 2.0
9.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
10.ポリオキシエチレンソルビタンモノオレエート(20E.O.)
2.0
11.香料 0.1
12.プロピレングリコール 1.0
13.グリセリン 2.0
14.パラオキシ安息香酸メチル 0.2
15.精製水にて全量を100とする
[製造方法]成分4〜10を加熱溶解して混合し、70
℃に保ち油相とする。成分1〜3及び12〜15を加熱
溶解して混合し、75℃に保ち水相とする。油相に水相
を加えて乳化して、かき混ぜながら冷却し、45℃にて
成分11を加え、更に30℃まで冷却して製品とする。Example 3 Emulsion formulation Compounding amount 1. Disodium edetate 0.5 part 2. Tocopherol acetate 1.0 3. 3. Acid-soluble atherosclerotic marine collagen solution (manufactured by Ihara Suisan) 1.0 4. Squalane 5.0 5. Olive oil 5.0 6. Jojoba oil 5.0 7. Cetanol 1.5 8. Glycerin monostearate 2.0 9. Polyoxyethylene cetyl ether (20 EO) 3.0 10. Polyoxyethylene sorbitan monooleate (20EO) 2.0 11. Perfume 0.1 12. Propylene glycol 1.0 13. Glycerin 2.0 14. Methyl paraoxybenzoate 0.2 15. [Manufacturing method] The total amount is 100 with purified water. Components 4 to 10 are dissolved by heating and mixed, and 70
Keep at ℃ and use as oil phase. Components 1 to 3 and 12 to 15 are dissolved by heating and mixed, and the mixture is kept at 75 ° C to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, the mixture is cooled with stirring, component 11 is added at 45 ° C, and further cooled to 30 ° C to obtain a product.
【0025】
実施例4 ゲル剤
処方 配合量
1.エデト酸2ナトリウム 0.1部
2.酸可溶性アテロ化マリンコラーゲン溶液(井原水産製) 20.0
3.エタノール 5.0
4.パラオキシ安息香酸メチル 0.1
5.ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.1
6.香料 適量
7.1,3−ブチレングリコール 5.0
8.グリセリン 5.0
9.キサンタンガム 0.1
10.水酸化カリウム 0.2
11.精製水にて全量を100とする
[製造方法]成分1、2及び7〜11と、成分3〜6を
それぞれ均一に溶解し、両者を混合して製品とする。Example 4 Gel formulation Formulation amount 1. Disodium edetate 0.1 part 2. Acid-soluble atherinated marine collagen solution (Ibara Suisan) 20.0 3. Ethanol 5.0 4. Methyl paraoxybenzoate 0.1 5. Polyoxyethylene hydrogenated castor oil (60 EO) 0.1 6. Fragrance suitable amount 7.1,3-butylene glycol 5.0 8. Glycerin 5.0 9. Xanthan gum 0.1 10. Potassium hydroxide 0.2 11. [Manufacturing method] The total amount is 100 with purified water Components 1, 2 and 7 to 11 and components 3 to 6 are uniformly dissolved, and both are mixed to obtain a product.
【0026】 実施例5 パック 処方 配合量 1.エデト酸2ナトリウム 0.2部 2.水溶性マリンコラーゲン溶液(テクノーブル製) 10.0 3.ポリビニルアルコール 12.0 4.エタノール 5.0 5.1,3−ブチレングリコール 8.0 6.パラオキシ安息香酸メチル 0.2 7.ポリオキシエチレン硬化ヒマシ油(20E.O.) 0.5 8.クエン酸 0.1 9.クエン酸ナトリウム 0.3 10.香料 適量 11.精製水にて全量を100とする [製造方法]成分1〜11を均一に溶解し製品とする。[0026] Example 5 Pack Prescription amount 1. Disodium edetate 0.2 parts 2. Water-soluble marine collagen solution (Technoble) 10.0 3. Polyvinyl alcohol 12.0 4. Ethanol 5.0 5.1,3-butylene glycol 8.0 6. Methyl paraoxybenzoate 0.2 7. Polyoxyethylene hydrogenated castor oil (20EO) 0.5 8. Citric acid 0.1 9. Sodium citrate 0.3 10. Fragrance suitable amount 11. Adjust the total volume to 100 with purified water [Production method] Components 1 to 11 are uniformly dissolved to obtain a product.
【0027】
実施例6 ファンデーション
処方 配合量
1.エデト酸2ナトリウム 0.5部
2.酸可溶性アテロ化マリンコラーゲン溶液(井原水産製) 0.01
3.ステアリン酸 2.4
4.ポリオキシエチレンソルビタンモノステアレート(20E.O.)
1.0
5.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
6.セタノール 1.0
7.液状ラノリン 2.0
8.流動パラフィン 3.0
9.ミリスチン酸イソプロピル 6.5
10.パラオキシ安息香酸ブチル 0.1
11.カルボキシメチルセルロースナトリウム 0.1
12.プロピレングリコール 4.0
13.トリエタノールアミン 1.1
14.パラオキシ安息香酸メチル 0.2
15.二酸化チタン 8.0
16.タルク 4.0
17.ベンガラ 1.0
18.黄酸化鉄 2.0
19.香料 適量
20.精製水にて全量を100とする
[製造方法]成分3〜10を加熱溶解し、80℃に保ち
油相とする。成分20に成分11をよく膨潤させ、続い
て、成分1、2及び12〜14を加えて均一に混合す
る。これに粉砕機にて粉砕混合した成分15〜18を加
え、ホモミキサーにて撹拌し、75℃に保ち水相とす
る。この水相に油相をかき混ぜながら加え、冷却し、4
5℃にて成分19を加え、かき混ぜながら30℃まで冷
却して製品とする。Example 6 Foundation Formulation Amount 1. Disodium edetate 0.5 part 2. Acid-soluble atherinated marine collagen solution (Ihara Suisan) 0.01 3. Stearic acid 2.4 4. Polyoxyethylene sorbitan monostearate (20EO) 1.0 5. Polyoxyethylene cetyl ether (20 EO) 2.0 6. Cetanol 1.0 7. Liquid lanolin 2.0 8. Liquid paraffin 3.0 9. Isopropyl myristate 6.5 10. Butyl paraoxybenzoate 0.1 11. Carboxymethyl cellulose sodium 0.1 12. Propylene glycol 4.0 13. Triethanolamine 1.1 14. Methyl paraoxybenzoate 0.2 15. Titanium dioxide 8.0 16. Talc 4.0 17. Red iron oxide 1.0 18. Yellow iron oxide 2.0 19. Perfume appropriate amount 20. [Production method] Components 3 to 10 are heated and dissolved in purified water to a total amount of 100 and kept at 80 ° C to form an oil phase. The component 11 is swelled well in the component 20, and subsequently, the components 1, 2 and 12 to 14 are added and mixed uniformly. Components 15 to 18 crushed and mixed with a crusher are added to this, and the mixture is stirred with a homomixer and kept at 75 ° C to form an aqueous phase. Add the oil phase to this water phase while stirring and cool.
Ingredient 19 is added at 5 ° C, and the product is cooled to 30 ° C with stirring.
【0028】 実施例7 浴用剤 処方 配合量 1.エデト酸2ナトリウム 1部 2.水溶性マリンコラーゲン溶液の凍結乾燥品(テクノーブル製) 5 3.炭酸水素ナトリウム 50 4.黄色202号(1) 適量 5.香料 適量 6.無水硫酸ナトリウムにて全量を100とする [製造方法]成分1〜6を均一に混合し製品とする。[0028] Example 7 Bath agent Prescription amount 1. Disodium edetate 1 part 2. Freeze-dried water-soluble marine collagen solution (Technoble) 5 3. Sodium hydrogen carbonate 50 4. Yellow No. 202 (1) Suitable amount 5. Fragrance suitable amount 6. Adjust the total amount to 100 with anhydrous sodium sulfate [Production method] Components 1 to 6 are uniformly mixed to obtain a product.
【0029】次に、本発明の効果を詳細に説明するた
め、実験例を挙げる。Next, in order to explain the effects of the present invention in detail, experimental examples will be given.
【0030】比較例1 比較クリーム1
実施例1において、エデト酸2ナトリウムを酢酸トコフ
ェロールに置き換えたものを比較クリーム1とした。Comparative Example 1 Comparative Cream 1 Comparative Example 1 was prepared by replacing the disodium edetate with tocopherol acetate in Example 1.
【0031】比較例2 比較クリーム2
実施例1において、エデト酸2ナトリウムをジブチルヒ
ドロキシトルエンに置き換えたものを比較クリーム2と
した。Comparative Example 2 Comparative Cream 2 Comparative Example 2 was prepared by replacing the disodium edetate in Example 1 with dibutylhydroxytoluene.
【0032】比較例3 比較クリーム3
実施例1において、エデト酸2ナトリウムをセサモール
に置き換えたものを比較クリーム3とした。Comparative Example 3 Comparative Cream 3 Comparative Example 3 was prepared by replacing the disodium edetate with sesamol in Example 1.
【0033】比較例4 従来クリーム
実施例1において、エデト酸2ナトリウムを精製水に置
き換えたものを従来クリームとした。Comparative Example 4 Conventional Cream A conventional cream was prepared by replacing the disodium edetate with purified water in Example 1.
【0034】実験例1 異臭防止試験1
実施例1のクリームのエデト酸2ナトリウムの濃度を0
〜5%に替えたクリームを用いて異臭防止効果の試験を
行った。すなわち、全てのクリームを40℃の恒温室で
3ヶ月保持し、保持後にクリームの臭いを女性20人
(25〜40才)で確認した。その結果、表1に示すよ
うにエデト酸2ナトリウムを配合しないものには異臭防
止効果は認められず、0.005%配合品からわずかな
効果を認め、0.05%以上で十分な効果が得られた。
しかし、クリームの変化を観察した結果、5%配合品で
は異臭防止効果は良好であったが、エデト酸2ナトリウ
ムが析出したため、好ましい状態ではなかった。その他
については良好であった。これらのことより、エデト酸
2ナトリウムの配合量は0.05%〜3%がより望まし
いことがわかった。Experimental Example 1 Odor Prevention Test 1 The concentration of disodium edetate in the cream of Example 1 was set to 0.
A test for the effect of preventing off-flavor was conducted using the cream replaced with -5%. That is, all the creams were held in a thermostatic chamber at 40 ° C. for 3 months, and after the holding, the smell of the cream was confirmed by 20 women (25 to 40 years old). As a result, as shown in Table 1, those having no edetate disodium were not observed to have an offensive odor-preventing effect. Was obtained.
However, as a result of observing changes in the cream, the 5% blended product had a good off-odor prevention effect, but was not in a preferable state because disodium edetate was precipitated. Others were good. From these, it was found that the disodium edetate content was more preferably 0.05% to 3%.
【0035】[0035]
【表1】表1.異臭防止試験結果 [Table 1] Table 1. Odor prevention test results
【0036】実験例2 異臭防止試験2
比較クリーム1の酢酸トコフェロールの濃度を0〜5%
に替えたクリームを用いて異臭防止効果の試験を行っ
た。すなわち、全てのクリームを40℃の恒温室で3ヶ
月保持し、保持後にクリームの臭いを女性20人(25
〜40才)で確認した。その結果、表2に示すように酢
酸トコフェロールを配合しないものには異臭防止効果は
認められず、0.005%配合品からわずかな効果を認
め、0.05%以上で十分な効果が得られた。しかしク
リームの変化を観察した結果、5%配合品では異臭防止
効果は良好であったが酢酸トコフェロールが分離したた
め、好ましい状態ではなかった。その他については良好
であった。これらのことより、酢酸トコフェロールの配
合量は0.05%〜3%がより望ましいことがわかっ
た。Experimental Example 2 Odor prevention test 2 The concentration of tocopherol acetate in Comparative Cream 1 was 0 to 5%.
A test for the effect of preventing offensive odor was conducted using the cream replaced with. That is, all the creams were kept in a thermostatic chamber at 40 ° C. for 3 months, and after being kept, the smell of the cream was changed by 20 women (25
~ 40 years old). As a result, as shown in Table 2, those having no tocopherol acetate were not observed to have an offensive odor-preventing effect, a slight effect was observed from the 0.005% blended product, and sufficient effect was obtained at 0.05% or more It was However, as a result of observing the change of the cream, the 5% blended product had a good offensive odor-preventing effect, but the tocopherol acetate was separated, which was not a preferable state. Others were good. From these, it was found that the blending amount of tocopherol acetate is more preferably 0.05% to 3%.
【0037】[0037]
【表2】表2.異臭防止試験結果 [Table 2] Table 2. Odor prevention test results
【0038】実験例7 異臭防止試験3
実施例1のクリームと比較例1の比較クリーム1、比較
例2の比較クリーム2、比較例3の比較クリーム3及び
比較例4の従来のクリームを用いて異臭防止効果の試験
を行った。すなわち、全てのクリームを40℃の恒温室
で2週間保持し、保持後にクリームの臭いを女性20人
(25〜40才)で確認した。その結果、表3に示すよ
うに酸化防止剤を配合したクリームは、従来クリームよ
り優れた効果を示し、中でも実施例1クリーム及び比較
クリーム1がよい効果を示した。これらのことより酸化
防止剤は魚由来酸可溶性アテロ化コラーゲン溶液の異臭
を防止し、中でもエデト酸2ナトリウム、酢酸トコフェ
ロールの効果が高く、酸化防止剤を配合することで優れ
た異臭防止効果を示すことが明かとなった。実施例2〜
7の化粧品も同様の試験を行い、良好な結果が得られ
た。Experimental Example 7 Odor Prevention Test 3 Using the cream of Example 1 and the comparative cream 1 of Comparative Example 1, the comparative cream 2 of Comparative Example 2, the comparative cream 3 of Comparative Example 3 and the conventional cream of Comparative Example 4. A test for the effect of preventing offensive odor was conducted. That is, all the creams were kept in a thermostatic chamber at 40 ° C. for 2 weeks, and the smell of the cream was confirmed by 20 women (25 to 40 years old) after the holding. As a result, as shown in Table 3, the cream containing the antioxidant showed a superior effect to the conventional cream, and the cream of Example 1 and the comparative cream 1 showed a good effect. From these facts, the antioxidant prevents the offensive odor of the fish-derived acid-soluble atelocollagen collagen solution, and among them, the effects of disodium edetate and tocopherol acetate are high, and the addition of the antioxidant exhibits an excellent anti-odor effect. It became clear. Examples 2 to
A similar test was performed on the cosmetic of No. 7, and good results were obtained.
【0039】[0039]
【表3】表3.異臭防止試験結果 [Table 3] Table 3. Odor prevention test results
【0040】[0040]
【発明の効果】以上のことから、本発明は、魚由来コラ
ーゲンと酸化防止剤を含有すること、特にエデト酸又は
その塩、及び/又はトコフェロール又はその誘導体を含
有することで異臭防止効果に優れた作用を示した。From the above, the present invention is excellent in the effect of preventing offensive odors by containing fish-derived collagen and an antioxidant, particularly by containing edetic acid or its salt, and / or tocopherol or its derivative. Showed the action.
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 R U 7/02 7/02 Z 7/48 7/48 7/50 7/50 (72)発明者 中田 悟 名古屋市西区鳥見町2−7 日本メナード 化粧品株式会社総合研究所内 Fターム(参考) 4C083 AA082 AA122 AB032 AB232 AB242 AB312 AB352 AB432 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC352 AC422 AC432 AC442 AC482 AC531 AC532 AC542 AC842 AD112 AD272 AD352 AD431 AD432 AD512 AD661 AD662 BB47 CC04 CC05 CC07 CC12 CC25 DD23 DD27 DD31 DD41 EE01 EE41 Front page continuation (51) Int.Cl. 7 identification code FI theme code (reference) A61K 7/00 A61K 7/00 RU 7/02 7/02 Z 7/48 7/48 7/50 7/50 ( 72) Inventor Satoru Nakata 2-7 Torimicho, Nishi-ku, Nagoya-shi Nippon Menard Cosmetics Co., Ltd. Research Institute F-term (reference) 4C083 AA082 AA122 AB032 AB232 AB242 AB312 AB352 AB432 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC352 AC422 AC432 AC442 AC482 AC531 AC532 AC542 AC842 AD112 AD272 AD352 AD431 AD432 AD512 AD661 AD662 BB47 CC04 CC05 CC07 CC12 CC25 DD23 DD27 DD31 DD41 EE01 EE41
Claims (5)
ことを特徴とした化粧料。1. A cosmetic comprising collagen derived from fish and an antioxidant.
又はトコフェロール又はその誘導体であることを特徴と
した請求項1の化粧料。2. The antioxidant is edetic acid or a salt thereof, and / or
Alternatively, the cosmetic according to claim 1, which is tocopherol or a derivative thereof.
001〜50%、エデト酸又はその塩の配合量が0.0
05〜5%、トコフェロール又はその誘導体の配合量が
0.005〜5%であることを特徴とした請求項2の化
粧料。3. A collagen content of 0.0 as a solid content.
001 to 50%, the amount of edetic acid or its salt is 0.0
The cosmetic according to claim 2, wherein the content of the tocopherol or its derivative is 0.005 to 5%.
性コラーゲンである請求項1ないし3の化粧料。4. The cosmetic material according to claim 1, wherein the collagen is atelolated collagen or water-soluble collagen.
とを特徴とする請求項4の化粧料。5. The cosmetic material according to claim 4, wherein the collagen is atelocollagen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001400323A JP2003201211A (en) | 2001-12-28 | 2001-12-28 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001400323A JP2003201211A (en) | 2001-12-28 | 2001-12-28 | Cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003201211A true JP2003201211A (en) | 2003-07-18 |
Family
ID=27639841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001400323A Pending JP2003201211A (en) | 2001-12-28 | 2001-12-28 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003201211A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006067874A (en) * | 2004-09-01 | 2006-03-16 | Sanei Gen Ffi Inc | Peptide-containing beverage |
| JP2012206966A (en) * | 2011-03-29 | 2012-10-25 | Katakura Chikkarin Co Ltd | Collagen originated in marine organism containing iii type collagen, and derivative thereof |
| JP2014136676A (en) * | 2013-01-15 | 2014-07-28 | Tokyo Institute Of Technology | Collagen-containing composition |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06279231A (en) * | 1993-03-31 | 1994-10-04 | Kawaken Fine Chem Co Ltd | Cosmetic |
| JPH09111237A (en) * | 1995-10-20 | 1997-04-28 | T Hasegawa Co Ltd | Antioxidant for docosahexaenoic acids |
| JPH09263784A (en) * | 1996-03-28 | 1997-10-07 | Snow Brand Milk Prod Co Ltd | Fat or oil containing polyunsaturated fatty acid and its production |
| JPH10330781A (en) * | 1997-05-30 | 1998-12-15 | Sugou:Kk | Composition containing highly unsaturated fatty acid and/or ester thereof |
| JPH1121218A (en) * | 1997-07-03 | 1999-01-26 | Lion Corp | Oral composition |
| JP2000050811A (en) * | 1998-08-11 | 2000-02-22 | Ihara Suisan Kk | Production of collagen of fishes |
| JP2000229832A (en) * | 1999-02-09 | 2000-08-22 | Shiseido Co Ltd | Skin lotion |
| JP2000256398A (en) * | 1999-03-09 | 2000-09-19 | Katakura Chikkarin Co Ltd | Fish skin-derived collagen and cosmetics containing it |
| JP2002226356A (en) * | 2001-02-06 | 2002-08-14 | Ichimaru Pharcos Co Ltd | Collagen-containing cosmetic composition derived from pigment-free fish skin |
| JP2003146835A (en) * | 2001-11-09 | 2003-05-21 | Pola Chem Ind Inc | Cosmetic with moisturizing effect |
-
2001
- 2001-12-28 JP JP2001400323A patent/JP2003201211A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06279231A (en) * | 1993-03-31 | 1994-10-04 | Kawaken Fine Chem Co Ltd | Cosmetic |
| JPH09111237A (en) * | 1995-10-20 | 1997-04-28 | T Hasegawa Co Ltd | Antioxidant for docosahexaenoic acids |
| JPH09263784A (en) * | 1996-03-28 | 1997-10-07 | Snow Brand Milk Prod Co Ltd | Fat or oil containing polyunsaturated fatty acid and its production |
| JPH10330781A (en) * | 1997-05-30 | 1998-12-15 | Sugou:Kk | Composition containing highly unsaturated fatty acid and/or ester thereof |
| JPH1121218A (en) * | 1997-07-03 | 1999-01-26 | Lion Corp | Oral composition |
| JP2000050811A (en) * | 1998-08-11 | 2000-02-22 | Ihara Suisan Kk | Production of collagen of fishes |
| JP2000229832A (en) * | 1999-02-09 | 2000-08-22 | Shiseido Co Ltd | Skin lotion |
| JP2000256398A (en) * | 1999-03-09 | 2000-09-19 | Katakura Chikkarin Co Ltd | Fish skin-derived collagen and cosmetics containing it |
| JP2002226356A (en) * | 2001-02-06 | 2002-08-14 | Ichimaru Pharcos Co Ltd | Collagen-containing cosmetic composition derived from pigment-free fish skin |
| JP2003146835A (en) * | 2001-11-09 | 2003-05-21 | Pola Chem Ind Inc | Cosmetic with moisturizing effect |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006067874A (en) * | 2004-09-01 | 2006-03-16 | Sanei Gen Ffi Inc | Peptide-containing beverage |
| JP2012206966A (en) * | 2011-03-29 | 2012-10-25 | Katakura Chikkarin Co Ltd | Collagen originated in marine organism containing iii type collagen, and derivative thereof |
| JP2014136676A (en) * | 2013-01-15 | 2014-07-28 | Tokyo Institute Of Technology | Collagen-containing composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000229832A (en) | Skin lotion | |
| JPH07300412A (en) | Active oxygen remover and composition containing the same | |
| JPH11263720A (en) | Antiaging agent | |
| JP2003048846A (en) | Collagenase inhibitor and anti-aging cosmetic | |
| JP2003192566A (en) | Cosmetic | |
| JP2009029734A (en) | External preparation for skin | |
| JP2003055190A (en) | Collagenase inhibitor and anti-aging cosmetic | |
| JP3170070B2 (en) | External preparation for skin | |
| JP2002121112A (en) | Skin care preparation | |
| JPH0253705A (en) | Cosmetic | |
| JP2003192528A (en) | Cosmetic | |
| JP2003048812A (en) | Elastase inhibitor and anti-aging cosmetic | |
| JPH04338313A (en) | Cosmetic | |
| JPH09131393A (en) | Deodorant, deodorizing composition, and deodorizing cosmetic | |
| JP2004161641A (en) | Cosmetic | |
| JP4824181B2 (en) | Topical skin preparation | |
| JPH06128142A (en) | External skin preparation | |
| JP3809003B2 (en) | Whitening agent | |
| JP2003201211A (en) | Cosmetic | |
| JPH07300422A (en) | Active oxygen eliminating agent and composition containing the same | |
| JP2003192567A (en) | Cosmetic | |
| JP2003192526A (en) | Cosmetic | |
| JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
| JP2003201210A (en) | Cosmetic | |
| JP3708485B2 (en) | Composition for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20041117 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041203 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050420 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050517 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050927 |